2201 Westlake Avenue, Suite 200
Seattle, WA 98121
United States
PATH
recombinant acellular pertussis vaccine, maternal immunisation, Pregnancy, immunogenicity, safety
SARS-CoV-2, COVID-19, Newcastle disease virus, Egg-based vaccine